Reply to Olivera and Mallat

Affiliations

Comment

Stanley C Jordan et al. Clin Infect Dis. 2021.

. 2021 Jul 1;73(1):e272-e273.

doi: 10.1093/cid/ciaa1287.

¹ Nephrology and Transplant Immunology, Cedars-Sinai Medical Center, Los Angeles, California.

No abstract available

Comment on

Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
Jordan SC, Zakowski P, Tran HP, Smith EA, Gaultier C, Marks G, Zabner R, Lowenstein H, Oft J, Bluen B, Le C, Shane R, Ammerman N, Vo A, Chen P, Kumar S, Toyoda M, Ge S, Huang E. Jordan SC, et al. Clin Infect Dis. 2020 Dec 15;71(12):3168-3173. doi: 10.1093/cid/ciaa812. Clin Infect Dis. 2020. PMID: 32575124 Free PMC article.
Efficacy of Tocilizumab For Treatment of Severe COVID-19 Pneumonia: More Evidence Is Needed.
De Oliveira B, Mallat J. De Oliveira B, et al. Clin Infect Dis. 2021 Jul 1;73(1):e271-e272. doi: 10.1093/cid/ciaa1284. Clin Infect Dis. 2021. PMID: 32886762 Free PMC article. No abstract available.